Alexander Robert Ingram Net Worth & Insider Trades
Alexander Robert Ingram Black Diamond Therapeutics, Inc
What is Alexander Robert Ingram's Net Worth?
The current estimated net worth of Black Diamond Therapeutics, Inc's Alexander Robert Ingram is estimated to be about $60.95M . Alexander Robert Ingram owns about 5,000 units of Black Diamond Therapeutics, Inc common stock. In the last 2 years at Black Diamond Therapeutics, Inc, Alexander Robert Ingram has sold an estimated value of $0 worth.
What is Alexander Robert Ingram's Past Insider Trading?
Alexander Robert Ingram's largest purchase order was 5,000 units , worth over $152.28K on October 1, 2020. In total, Alexander Robert Ingram has made about 12 transactions over 2 years of their time at Black Diamond Therapeutics, Inc. Alexander Robert Ingram usually trades in December, June and September, with the busiest year in 2022.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ALEXANDER ROBERT INGRAM
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
InsideArbitrage
What is Alexander Robert Ingram's' Mailing Address?
- Mailing address is 280 S. Mangum Street Suite 350 Durham NC 27701 NC
What are Black Diamond Therapeutics, Inc's Past Insider Trades?
Black Diamond Therapeutics, Inc's most recent insider trade came on October 19, 2023 by Growth Biotech V and BB Biotech Ag who bought 400,000 units worth $934.08K . In the last 3 years, insiders at Black Diamond Therapeutics, Inc have sold an estimated value of $27.71M and bought an estimated value of $115.35M worth of shares. Insider trading is most common in February and June, with the busiest year in 2020. The most active traders at the company are Phd Bradley Bolzon, Director, Versant Vantage I Lp, and Versant Venture Capital Vi Lp .
Black Diamond Therapeutics, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |